Studies suggest acupuncture may relieve pain and lymphedema in patients with cancer, but clinical trials are lacking.
Two recent studies demonstrate that microwave ablation offers rapid pain relief with few complications.
Managing pain as a result of cancer metastatic to the bone is an important element of a patient's overall treatment plan.
Duloxetine is effective in reducing pain in patients with painful chemotherapy-induced peripheral neuropathy, especially in those receiving drug as initial treatment.
Sublingual opioid sufentanil NanoTab PCA is superior to intravenous PCA morphine for post-surgical acute pain management.
The American Cancer Society is hosting live workshops about how patients' quality of life is improved when the palliative care conversation starts early.
An intervention with distress monitoring and needs assessment has not been shown to improve outcomes.
For post-radiotherapy survivors of head and neck cancer, depression is fairly common, but treatment is underutilized.
A pamphlet and talk about end-of-life decisions result in earlier do-not-resuscitate orders and less chance of death in the hospital.
Certain factors predict later anxiety, depression, and comorbid anxiety-depression in adult survivors of cancer.
Expansion of legalization may lead to greater acceptance of this alternative medicine.
Cancer-related fatigue affects many patients with cancer, but treating it properly can be a challenge.
Dexamethasone is more effective than placebo at reducing cancer-related fatigue, leading to improvements in QoL and physical distress.
Based on votes and responses to a NEJM interactive feature, 76% of clinicians support the use of medicinal marijuana.
Certain forms of exercise can help combat fatigue and other side effects from cancer treatment, leading to improved outcomes for patients.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|